两例IgG4相关疾病的个案报道
Two Case Reports of IgG4-Related Disease
DOI: 10.12677/acm.2026.1641747, PDF,    科研立项经费支持
作者: 朱新龙, 薛旭航:南京中医药大学第一临床医学院,江苏 南京;徐致远, 孙斯凡, 王旭方, 高 坤*:南京中医药大学附属医院肾内科,江苏 南京
关键词: IgG4相关疾病腹膜后纤维化肾小管间质性肾炎IgG4-Related Disease Retroperitoneal Fibrosis Tubulointerstitial Nephritis
摘要: 目的:探讨IgG4相关疾病的临床表现及诊治要点。方法:回顾分析我院收治的2例IgG4相关疾病的临床资料。结果:例1因咳嗽、胸腔积液入住外院,查CT示腹主动脉周围及肠系膜根部软组织密度占位,双侧输尿管中下段包绕双侧输尿管及肾盂肾盏扩张积液,PET-CT示全身多组淋巴结肿大伴FDG代谢增高,考虑血液系统疾病,恶性淋巴瘤可能。后入住我院,辅助检查提示全血细胞减少、血肌酐升高、血清IgG4及IgE水平升高。淋巴结病理:符合IgG4相关性淋巴结病。治疗上予醋酸泼尼松片30 mg qd口服。2月后随诊,患者血常规及血清肌酐水平在正常范围。例2体检查肌酐165 μmol/L,因疲倦乏力入外院,查血肌酐198 μmol/L,血清IgG4升高,上腹部核磁提示:胆管支架术后观,胰腺萎缩,胰管轻度扩张。入院前查血肌酐440.0 μmol/L,后入住我院,查血清IgG4升高、双肾实质损害,诊断考虑IgG4相关性肾病。治疗上予甲泼尼龙片24 mg qd口服,治疗2周后复查肌酐下降,随访17月,肌酐波动300~400 μmol/L,IgG4持续转阴。结论:IgG4相关疾病临床上可累及多个系统,临床上容易误诊,组织病理及血清IgG4检测有助于病情诊断。
Abstract: Objective: To investigate the clinical manifestations and key points of diagnosis and treatment of IgG4-related disease. Methods: A retrospective analysis of clinical data from two patients with IgG4-related disease admitted to our hospital. Results: Case 1 was admitted to another hospital due to cough and pleural effusion. CT scans revealed soft tissue masses of increased density around the abdominal aorta and at the root of the mesentery, encasement of the middle and lower segments of both ureters, and dilation and hydronephrosis of both ureters and renal pelvis. PET-CT showed generalized lymphadenopathy with increased FDG uptake, suggesting a hematologic disorder, possibly malignant lymphoma. The patient was subsequently admitted to our hospital. Auxiliary tests revealed pancytopenia, elevated serum creatinine, and elevated serum IgG4 and IgE levels. Lymph node pathology was consistent with IgG4-related lymphadenopathy. Treatment consisted of oral prednisone acetate 30 mg once daily. At a follow-up visit two months later, the patient’s complete blood count and serum creatinine levels were within normal ranges. Case 2: During a physical examination, serum creatinine was 165 μmol/L. The patient was admitted to another hospital due to fatigue and weakness, where serum creatinine was 198 μmol/L and serum IgG4 was elevated. An upper abdominal MRI revealed post-biliary stent placement findings, pancreatic atrophy, and mild pancreatic duct dilation. Pre-admission serum creatinine was 440.0 μmol/L. The patient was subsequently admitted to our hospital, where elevated serum IgG4 and bilateral renal parenchymal damage were noted, leading to a diagnosis of IgG4-related nephropathy. Treatment consisted of oral methylprednisolone 24 mg once daily. After 2 weeks of treatment, serum creatinine levels decreased. During a 17-month follow-up, serum creatinine fluctuated between 300 and 400 μmol/L, and serum IgG4 remained negative. Conclusion: IgG4-related disease can clinically affect multiple systems and is prone to misdiagnosis. Histopathological examination and serum IgG4 testing are helpful for diagnosis.
文章引用:朱新龙, 薛旭航, 徐致远, 孙斯凡, 王旭方, 高坤. 两例IgG4相关疾病的个案报道[J]. 临床医学进展, 2026, 16(4): 4754-4761. https://doi.org/10.12677/acm.2026.1641747

参考文献

[1] Wallace, Z.S., Naden, R.P., Chari, S., Choi, H., Della‐Torre, E., Dicaire, J., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4‐Related Disease. Arthritis & Rheumatology, 72, 7-19. [Google Scholar] [CrossRef] [PubMed]
[2] Peyronel, F., Della-Torre, E., Maritati, F., Urban, M.L., Bajema, I., Schleinitz, N., et al. (2025) IgG4-Related Disease and Other Fibro-Inflammatory Conditions. Nature Reviews Rheumatology, 21, 275-290. [Google Scholar] [CrossRef] [PubMed]
[3] Kawano, M. and Saeki, T. (2015) IgG4-Related Kidney Disease—An Update. Current Opinion in Nephrology and Hypertension, 24, 193-201. [Google Scholar] [CrossRef] [PubMed]
[4] Parums, D.V. (2025) IgG4-Related Disease: A Review of Persistent Challenges in the Pathogenesis, Diagnosis, and Approaches to Treatment. Medical Science Monitor, 31, e950212. [Google Scholar] [CrossRef] [PubMed]
[5] Arias-Intriago, M., Gomolin, T., Jaramillo, F., Cruz-Enríquez, A.C., Lara-Arteaga, A.L., Tello-De-la-Torre, A., et al. (2025) IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis. International Journal of Molecular Sciences, 26, Article No. 5325. [Google Scholar] [CrossRef] [PubMed]
[6] Masamune, A., Kikuta, K., Hamada, S., Tsuji, I., Takeyama, Y., Shimosegawa, T., et al. (2020) Nationwide Epidemiological Survey of Autoimmune Pancreatitis in Japan in 2016. Journal of Gastroenterology, 55, 462-470. [Google Scholar] [CrossRef] [PubMed]
[7] Wallace, Z.S., Miles, G., Smolkina, E., Petruski-Ivleva, N., Madziva, D., Cook, C., et al. (2023) Incidence, Prevalence and Mortality of IgG4-Related Disease in the USA: A Claims-Based Analysis of Commercially Insured Adults. Annals of the Rheumatic Diseases, 82, 957-962. [Google Scholar] [CrossRef] [PubMed]
[8] Jha, I., McMahon, G.A., Perugino, C.A., Katz, G., Wallace, Z.S., Fernandes, A., et al. (2024) Sex as a Predictor of Clinical Phenotype and Determinant of Immune Response in IgG4-Related Disease: A Retrospective Study of Patients Fulfilling the American College of Rheumatology—European League against Rheumatism Classification Criteria. The Lancet Rheumatology, 6, e460-e468. [Google Scholar] [CrossRef] [PubMed]
[9] Ko, J., Lee, M.J., Khwarg, S.I., Yoon, J.S., Yang, S., Son, J., et al. (2025) Immunoglobulin G4-Related Ophthalmic Disease. Ophthalmology, 132, 995-1004. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, S., Qin, X., Jin, Z. and Yang, L. (2025) A Comprehensive Review of IgG4-Related Pancreatitis: Pathogenesis, Diagnosis, and Therapeutic Advances. Frontiers in Immunology, 16, Article ID: 1590902. [Google Scholar] [CrossRef] [PubMed]
[11] Beuers, U. and Trampert, D.C. (2025) IgG4-Related Cholangitis. Seminars in Liver Disease, 45, 381-396. [Google Scholar] [CrossRef] [PubMed]
[12] Kawano, M. (2025) Update on IgG4-Related Periaortitis/Retroperitoneal Fibrosis and Periarteritis-Recent Clinical, Diagnostic and Therapeutic Advances. Seminars in Arthritis and Rheumatism, 72, Article ID: 152691. [Google Scholar] [CrossRef] [PubMed]
[13] Ghaffari Jolfayi, A., Salmanipour, A., Heshmat-Ghahdarijani, K., Meshgi, S., Dastmardi, M., Salehabadi, G., et al. (2025) Imaging Findings in Cardiovascular Involvements of IgG4-Related Disease: A Systematic Review Study. Rheumatology, 64, 943-951. [Google Scholar] [CrossRef] [PubMed]
[14] Ebrahimi, N., Ha, V., Whittier, W., Efe, O., Kronbichler, A., Grace Choung, H.Y., et al. (2025) IgG4-Related Kidney Disease. Clinical Journal of the American Society of Nephrology, 20, 588-590. [Google Scholar] [CrossRef] [PubMed]
[15] Kawano, M., Saeki, T., Ubara, Y. and Matsui, S. (2023) Recent Advances in IgG4-Related Kidney Disease. Modern Rheumatology, 33, 242-251. [Google Scholar] [CrossRef] [PubMed]
[16] Petelytska, L., Nikitina, A., Tarasenko, O., Chechotenko, I., Mykhailov, D., Kravchenko, V., et al. (2023) IgG4-Related Retroperitoneal Fibrosis with Acute Kidney Injury: A Case Report and Literature Review. Rheumatology International, 43, 2141-2153. [Google Scholar] [CrossRef] [PubMed]
[17] Okamoto, A., Watanabe, T., Kamata, K., Minaga, K. and Kudo, M. (2019) Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis. Internal Medicine, 58, 1533-1539. [Google Scholar] [CrossRef] [PubMed]
[18] Shiokawa, M., Kodama, Y., Yoshimura, K., Kawanami, C., Mimura, J., Yamashita, Y., et al. (2013) Risk of Cancer in Patients with Autoimmune Pancreatitis. American Journal of Gastroenterology, 108, 610-617. [Google Scholar] [CrossRef] [PubMed]
[19] Wallace, Z.S., Naden, R.P., Chari, S., Choi, H.K., Della-Torre, E., Dicaire, J., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4-Related Disease. Annals of the Rheumatic Diseases, 79, 77-87. [Google Scholar] [CrossRef] [PubMed]
[20] Ichiki, A., Hashimoto, N., Ueda, T., Hiraiwa, S., Tajiri, T., Nakamura, N., et al. (2016) IgG4-Related Disease with Bone Marrow Involvement. Internal Medicine, 55, 2295-2299. [Google Scholar] [CrossRef] [PubMed]
[21] Shimazu, Y., Uchiyama, T., Mizumoto, C., Takeoka, T., Tsuji, M., Tomo, K., et al. (2018) Concurrent Autoimmune Neutropenia and Idiopathic Thrombocytopenic Purpura Associated with IgG4-Related Disease. Internal Medicine, 57, 1911-1916. [Google Scholar] [CrossRef] [PubMed]
[22] Peyronel, F. and Vaglio, A. (2023) IgG4-Related Kidney Disease. Clinical Journal of the American Society of Nephrology, 18, 994-996. [Google Scholar] [CrossRef] [PubMed]
[23] Stone, J.H. (2025) IgG4-Related Disease: Lessons from the First 20 Years. Rheumatology, 64, i24-i27. [Google Scholar] [CrossRef] [PubMed]
[24] Raissian, Y., Nasr, S.H., Larsen, C.P., Colvin, R.B., Smyrk, T.C., Takahashi, N., et al. (2011) Diagnosis of IgG4-Related Tubulointerstitial Nephritis. Journal of the American Society of Nephrology, 22, 1343-1352. [Google Scholar] [CrossRef] [PubMed]
[25] 张文, 董凌莉, 朱剑, 等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志, 2021, 60(3): 192-206.
[26] Umehara, H., Okazaki, K., Kawa, S., Takahashi, H., Goto, H., Matsui, S., et al. (2021) The 2020 Revised Comprehensive Diagnostic (RCD) Criteria for IgG4-rd. Modern Rheumatology, 31, 529-533. [Google Scholar] [CrossRef] [PubMed]
[27] Tsuge, S., Fujii, H., Tamai, M., Tsujiguchi, H., Yoshida, M., Suzuki, N., et al. (2024) Factors Related to Elevated Serum Immunoglobulin G4 (IgG4) Levels in a Japanese General Population. Arthritis Research & Therapy, 26, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
[28] 费允云, 刘燕鹰, 董凌莉, 等. IgG4相关性疾病诊疗规范[J]. 中华内科杂志, 2023, 62(10): 1161-1171.
[29] Khosroshahi, A., Wallace, Z.S., Crowe, J.L., Akamizu, T., Azumi, A., Carruthers, M.N., et al. (2015) International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease. Arthritis & Rheumatology, 67, 1688-1699. [Google Scholar] [CrossRef] [PubMed]
[30] Stone, J.H., Khosroshahi, A., Zhang, W., Della Torre, E., Okazaki, K., Tanaka, Y., et al. (2025) Inebilizumab for Treatment of IgG4-Related Disease. New England Journal of Medicine, 392, 1168-1177. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, Y., Ye, C., Yang, P., Zhang, W., Dai, L., Wei, W., et al. (2025) Thalidomide Can Effectively Prevent Relapse in IgG4-Related Disease Outweighing Its Side Effects: A Multicentre, Randomised, Double-Blinded, Placebo-Controlled Study. Annals of the Rheumatic Diseases, 84, 1246-1252. [Google Scholar] [CrossRef] [PubMed]
[32] Yan, S., Peng, Y., Xu, J., et al. (2025) Genome-Wide Association Studies Reveal New Insights into the Genetic Basis of IgG4-Related Disease in the Chinese Han Population. Annals of the Rheumatic Diseases, 85, 693-703.
[33] Sasaki, T., Akiyama, M., Kaneko, Y., et al. (2018) Risk Factors of Relapse Following Glucocorticoid Tapering in IgG4-Related Disease. Clinical and Experimental Rheumatology, 36, 186-189.
[34] Ji, Z.F., Ma, L.Y., Zhang, L.J., et al. (2021) Prognostic Factors in IgG4-Related Disease: A Long-Term Monocentric Chinese Cohort Study. Clinical Rheumatology, 40, 2293-2300. [Google Scholar] [CrossRef] [PubMed]